The diagnostic value of serum DSA-TRF in hepatocellular carcinoma

被引:0
|
作者
Wenqian Guan
Zhiyuan Gao
Chenjun Huang
Meng Fang
Huijuan Feng
Shipeng Chen
Mengmeng Wang
Jun Zhou
Song Hong
Chunfang Gao
机构
[1] Shanghai Eastern Hepatobiliary Surgery Hospital,Department of Laboratory Medicine
[2] Fujian Medical University,Clinical Medical College
[3] Medical School of Nanjing University,Department of Emergency Medicine, Jinling Hospital
来源
Glycoconjugate Journal | 2020年 / 37卷
关键词
Transferrin; Hepatocellular carcinoma; Glycan biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
TRF is a glycoprotein mainly secreted by hepatocytes, The aim of this study was to explore the diagnostic value of aberrant glycosylated serum transferrin (TRF) especially containing multi-antennary glycans in hepatocellular carcinoma (HCC).A total of 581 subjects including HCC patients, liver cirrhosis (LC) patients, chronic hepatitis (CHB) patients and healthy controls (HC) were recruited. All the subjects were randomly assigned to training group (n = 411) and validation group (n = 170). We firstly analyzed the serum protein N-glycome profiling of HCC, LC, and HC by DNA sequencer–assisted fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology. We established a lectin-antibody sandwich ELISA (Lectin-ELISA) method to detect multi-antennary glycans-contained TRF (DSA-TRF) in serum, in which Datura stramonium Agglutinin (DSA) was used for specific recognition. Levels of serum DSA-TRF and TRF were analyzed respectively. The diagnostic efficacies of DSA-TRF and TRF of differentiating HCC patients from CHB, LC patients and HC within the training group were evaluated using receiver operating characteristic (ROC) curve and tested in the validation group.The result found that in training group, serum TRF and DSA-TRF levels differed significantly between HCC (1.86 ± 0.50, g/L, 0.285 ± 0.06), CHB + LC (2.39 ± 0.74, g/L, 0.189 ± 0.07) and HC (1.92 ± 0.69, g/L, 0.249 ± 0.09) (HCC vs. CHB + LC, P < 0.001; HCC vs. HC, P < 0.001; CHB + LC vs. HC, P < 0.001). The area under the ROC curve (AUC) of DSA-TRF was significantly superior to AFP (0.880, 95%CI: 0.834–0.925 vs. 0.776, 95%CI: 0.725–0.827, P = 0.003) in differentiating HCC from CHB + LC. The AUC of diagnostic model GlycoTRF1 (0.981, 95%CI: 0.969–0.993) was higher than DSA-TRF and AFP alone (P<0.001) in differentiating HCC from CHB + LC, which was verified in validation group.The results indicated that the serum DSA-TRF might serve as a potential glycan biomarker for distinguishing HCC from CHB and LC.
引用
收藏
页码:231 / 240
页数:9
相关论文
共 50 条
  • [41] The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma
    Novruzov, Emil
    Mori, Yuriko
    Novruzov, Fuad
    PET CLINICS, 2023, 18 (03) : 309 - 314
  • [42] Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinoma
    Olufemi Michael Soyemi
    Jesse Abiodun Otegbayo
    Samuel Olawale Ola
    Adegboyega Akere
    Temitope Soyemi
    BMC Research Notes, 5 (1)
  • [43] ALDOA Has Potential Diagnostic Value in Hepatocellular Carcinoma and Promotes Hepatocellular Carcinoma Cell Proliferation and Tumorigenesis
    Wei, Xuyong
    Xu, Xiao
    Li, Jie
    Zhuang, Runzhou
    Zhang, Xuanyu
    Zhou, Lin
    Xie, Haiyang
    Yan, Sheng
    Shen, Yan
    Zheng, Shusen
    TRANSPLANTATION, 2016, 100 : S235 - S236
  • [44] DIAGNOSTIC VALUE OF SERUM PANCREATIC TISSUE CARCINOMA ANTIGEN IN PANCREATIC CARCINOMA
    孟济明
    许国铭
    沈茜
    张洪富
    吴月琴
    姚光弼
    Chinese Journal of Cancer Research, 1990, (03) : 71 - 73
  • [45] Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma
    Dong, Xueyan
    Hou, Qiang
    Chen, Yueming
    Wang, Xianjun
    DISEASE MARKERS, 2017, 2017
  • [46] Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA
    Wu, Jiali
    Xiang, Zheyi
    Bai, Le
    He, Lagu
    Tan, Li
    Hu, Min
    Ren, Yaping
    CANCER BIOMARKERS, 2018, 23 (02) : 235 - 242
  • [47] THE CLINICAL-VALUE OF SERUM FERRITIN IN HEPATOCELLULAR-CARCINOMA
    SIMONETTI, RG
    CRAXI, A
    DARDANONI, G
    LANZARONE, F
    BARBARIA, F
    COTTONE, M
    PAGLIARO, L
    HEPATO-GASTROENTEROLOGY, 1985, 32 (06) : 276 - 278
  • [48] Prognostic value of serum biological markers in patients with hepatocellular carcinoma
    Parasole, R
    Izzo, F
    Perrone, F
    Pignata, S
    Galati, MG
    Leonardi, E
    Castiglione, F
    Orlando, R
    Castello, G
    Esposito, G
    Gallo, C
    Daniele, B
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3504 - 3509
  • [49] Value of DSA in the Diagnostic Workup of Pulsatile Tinnitus
    Deuschl, Cornelius
    Goericke, Sophia
    Gramsch, Carolin
    Oezkan, Neriman
    Lehnerdt, Goetz
    Kastrup, Oliver
    Ringelstein, Adrian
    Wanke, Isabel
    Forsting, Michael
    Schlamann, Marc
    PLOS ONE, 2015, 10 (02):